FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Medical Device RWE Guidance

FDA publishes a guidance clarifying how it evaluates real-world data to determine if they are sufficient to provide real-world evidence for regulatory...

latest-news-card-1
Human Drugs

Merck Cholesterol, Cancer Drugs Added to Voucher Program

FDA selects investigational cholesterol and cancer drugs from Merck for expedited regulatory reviews under its Commissioner's National Priority Vouche...

latest-news-card-1
Human Drugs

FDA Warns Catalent Indiana for CGMP Lapses

FDA issues a Warning Letter to Catalents Bloomington, IN, drug manufacturing plant, citing significant manufacturing violations after investigators fo...

latest-news-card-1
Human Drugs

Change Premarin Prescribing Info to Include Equilin: Petition

Diamond Research Foundation founder Beth Rosenshein petitions FDA to update Premarin labeling with information on the estrogen hormone equilin that is...

latest-news-card-1

FDA Agentic AI Deployment Raises Concerns

Two Mintz attorneys urge stakeholders to monitor FDA communications involving compliance and review carefully, looking for issues with information tha...

latest-news-card-1
Human Drugs

GSK Long-Acting Biologic Approved for Asthma

FDA approves GSKs Exdensur (depemokimab-ulaa), an ultra-long-acting biologic for severe asthma.

Human Drugs

FDA Denies Akebia Reconsideration Petition

FDA denies an Akebia Therapeutics 2019 petition for reconsideration seeking five-year new chemical entity exclusivity for its Auryxia.

latest-news-card-1
Human Drugs

FDA Easing Drug Approval Standards: Column

A Medshadow column raises concerns about FDAs stated efforts to allow some drugs to be approved based on a single pivotal trial.

latest-news-card-1

Microvascular Tissue Marketing Unapproved New Drug

FDA warns San Diego, CA-based Microvascular Tissue about CGMP violations in its production and marketing of an unapproved new drug that is also an unl...

latest-news-card-1
FDA General

FDA Commissioner Defends Vaccine Stance, Transparency Push

In a recent interview, FDA commissioner Marty Makary positions himself as a supporter of vaccines while defending recent agency actions that have draw...